QEPEMRY

Serial Number 99184861
630

Registration Progress

Application Filed
May 20, 2025
Under Examination
Approved for Publication
Published for Opposition
Registered

Basic Information

Serial Number
99184861
Filing Date
May 20, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
630
Status Date
May 20, 2025
Application
Pending
Classes
005

Rights Holder

Eli Lilly and Company

03
Address
Lilly Corporate Center
Indianapolis, IN 46285

Ownership History

Eli Lilly and Company

Original Applicant
03
Indianapolis, IN

Legal Representation

Attorney
Bruce W. Longbottom

Application History

3 events
Date Code Type Description
May 20, 2025 MAFR O APPLICATION FILING RECEIPT MAILED
May 20, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 20, 2025 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer’s disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn’s disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, hearing loss, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, obstructive sleep apnea, osteoarthritis, pain, Parkinson’s disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases

Classification

International Classes
005